Atlas Trials

Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.

Clinical trial NCT06851962 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06851962
Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus Type 2
Start date
2025-05-26
Primary completion
2026-06-30
Enrollment
504

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.